There is no Press for this Ticker
Abliva AB is a Swedish company which is active in pharmaceutical development. Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.

Related Companies

TickerCompanyChg %Mkt Cap
NEVPFAbliva-1.08%35.1M

Abliva Company Questions & Answers

Q

How do I buy Abliva (NEVPF) stock?

A

You can purchase shares of Abliva (OTC: NEVPF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Abliva's (NEVPF) main competitors?

A

There are no as such competitors for Abliva.

Q

What is the target price for Abliva?

A

There is no analysis for Abliva

Q

How much is Abliva (NEVPF) stock ?

A

The stock price for Abliva (OTC: NEVPF) is $0.1186 last updated Fri Apr 09 2021 14:24:20 GMT+0000 (Coordinated Universal Time).

Q

When is the next Abliva (NEVPF) dividend?

A

There are no upcoming dividends for Abliva.

Q

When is Abliva (OTC:NEVPF) reporting earnings?

A

There are no earnings for Abliva

Q

When is the upcoming split for NEVPF?

A

There is no upcoming split for Abliva.